Business Description
Laekna Inc
ISIN : KYG5340S1093
Total Employee Number:
83Compare
Compare
Traded in other countries / regions
02105.Hong Kong4U4.Germany Index Membership
Hong Kong Stock Connect IPO Date
2023-06-29Description
Laekna Inc is a science-driven, clinical-stage biotechnology company. The company has established a comprehensive R&D infrastructure to accelerate the development of molecules from discovery to registrational trials. It has initiated seven clinical trials for LAE102, LAE103, LAE002 (afuresertib), LAE001 and LAE005 to address unmet medical needs in obesity and cancers. Laekna has two Core Products and other pipeline product candidates. Core Product LAE002 is an adenosine triphosphate (ATP) competitive AKT inhibitor for the treatment of ovarian cancer, prostate cancer, breast cancer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 10.45 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.54 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.94 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.4 | |||||
3-Year EPS without NRI Growth Rate | 17 | |||||
3-Year FCF Growth Rate | 33.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 23.85 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.35 | |||||
9-Day RSI | 42.95 | |||||
14-Day RSI | 43.68 | |||||
3-1 Month Momentum % | -47.13 | |||||
6-1 Month Momentum % | -47.41 | |||||
12-1 Month Momentum % | -60.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.54 | |||||
Quick Ratio | 5.54 | |||||
Cash Ratio | 5.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.6 | |||||
Shareholder Yield % | -23.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 80.98 | |||||
Operating Margin % | -245.85 | |||||
Net Margin % | -213.6 | |||||
EBITDA Margin % | -209.99 | |||||
FCF Margin % | -87.23 | |||||
OCF Margin % | -86.24 | |||||
ROE % | -25.67 | |||||
ROA % | -21.06 | |||||
ROIC % | -86.7 | |||||
3-Year ROIIC % | 102.38 | |||||
ROC (Joel Greenblatt) % | -2972.44 | |||||
ROCE % | -25.08 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 73.78 | |||||
PS Ratio | 20.65 | |||||
PB Ratio | 2.07 | |||||
Price-to-Tangible-Book | 2.31 | |||||
EV-to-EBIT | -6.35 | |||||
EV-to-EBITDA | -6.35 | |||||
EV-to-Revenue | 13.33 | |||||
EV-to-FCF | -15.28 | |||||
| Price-to-Net-Current-Asset-Value | 2.35 | |||||
| Price-to-Net-Cash | 2.38 | |||||
Earnings Yield (Greenblatt) % | -15.75 | |||||
FCF Yield % | -3.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Laekna Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 117.895 | ||
| EPS (TTM) (HK$) | -0.648 | ||
| Beta | 1.3363 | ||
| 3-Year Sharpe Ratio | 0.26 | ||
| 3-Year Sortino Ratio | 0.38 | ||
| Volatility % | 73.39 | ||
| 14-Day RSI | 43.68 | ||
| 14-Day ATR (HK$) | 0.566383 | ||
| 20-Day SMA (HK$) | 6.49475 | ||
| 12-1 Month Momentum % | -60.42 | ||
| 52-Week Range (HK$) | 5.37 - 19.6 | ||
| Shares Outstanding (Mil) | 449.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Laekna Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Laekna Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Laekna Inc Frequently Asked Questions
What is Laekna Inc(HKSE:02105)'s stock price today?
The current price of HKSE:02105 is HK$6.05. The 52 week high of HKSE:02105 is HK$19.60 and 52 week low is HK$5.37.
When is next earnings date of Laekna Inc(HKSE:02105)?
The next earnings date of Laekna Inc(HKSE:02105) is .
Does Laekna Inc(HKSE:02105) pay dividends? If so, how much?
Laekna Inc(HKSE:02105) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange | 2023-06-29 |
Articles on Laekna Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers